Mary E. Valiga

1.4k total citations
10 papers, 785 citations indexed

About

Mary E. Valiga is a scholar working on Hepatology, Immunology and Epidemiology. According to data from OpenAlex, Mary E. Valiga has authored 10 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 5 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Mary E. Valiga's work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (4 papers) and Immune Cell Function and Interaction (4 papers). Mary E. Valiga is often cited by papers focused on Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (4 papers) and Immune Cell Function and Interaction (4 papers). Mary E. Valiga collaborates with scholars based in United States, United Kingdom and South Korea. Mary E. Valiga's co-authors include Kyong‐Mi Chang, Nobuhiro Nakamoto, Emma Gostick, Kim M. Olthoff, Mary Kaminski, Gordon J. Freeman, Abraham Shaked, David A. Price, E. John Wherry and David E. Kaplan and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Mary E. Valiga

10 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Valiga United States 7 459 451 344 160 70 10 785
Cristina Mori Italy 8 309 0.7× 489 1.1× 436 1.3× 109 0.7× 66 0.9× 9 768
D. Tola Italy 3 485 1.1× 302 0.7× 267 0.8× 153 1.0× 75 1.1× 3 716
Luca Sacchelli Italy 6 475 1.0× 580 1.3× 541 1.6× 146 0.9× 121 1.7× 7 934
Nadine Kersting Germany 9 358 0.8× 364 0.8× 249 0.7× 89 0.6× 28 0.4× 12 589
Nicole Castelblanco United States 6 712 1.6× 338 0.7× 268 0.8× 195 1.2× 61 0.9× 6 897
Norbert H. Grüner Germany 9 398 0.9× 636 1.4× 570 1.7× 67 0.4× 76 1.1× 10 899
Yuji Sobao Japan 11 420 0.9× 215 0.5× 222 0.6× 121 0.8× 47 0.7× 14 627
Simon Hellier United Kingdom 8 232 0.5× 498 1.1× 416 1.2× 88 0.6× 83 1.2× 9 780
Martin Wächtler Germany 11 343 0.7× 412 0.9× 480 1.4× 78 0.5× 87 1.2× 15 718
Michelle Brown United States 4 420 0.9× 489 1.1× 515 1.5× 69 0.4× 81 1.2× 10 847

Countries citing papers authored by Mary E. Valiga

Since Specialization
Citations

This map shows the geographic impact of Mary E. Valiga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Valiga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Valiga more than expected).

Fields of papers citing papers by Mary E. Valiga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Valiga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Valiga. The network helps show where Mary E. Valiga may publish in the future.

Co-authorship network of co-authors of Mary E. Valiga

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Valiga. A scholar is included among the top collaborators of Mary E. Valiga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Valiga. Mary E. Valiga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cho, Hyosun, Masahiro Kikuchi, Yun Li, et al.. (2014). Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection. Frontiers in Immunology. 5. 265–265. 14 indexed citations
2.
Bunchorntavakul, Chalermrat, Lisa Jones, Masahiro Kikuchi, et al.. (2014). Distinct Features in Natural History and Outcomes of Acute Hepatitis C. Journal of Clinical Gastroenterology. 49(4). e31–e40. 14 indexed citations
3.
Hafkin, Jeffrey, Masahiro Kikuchi, Mary E. Valiga, et al.. (2012). Sa1966 A Comparison of the Clinical and Immunological Characteristics in Patients With Acute Hepatitis C With and Without HIV-Coinfection. Gastroenterology. 142(5). S–968. 1 indexed citations
4.
Nakamoto, Nobuhiro, Hyosun Cho, Abraham Shaked, et al.. (2009). Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade. PLoS Pathogens. 5(2). e1000313–e1000313. 303 indexed citations
5.
Kaplan, David E., Fusao Ikeda, Yun Li, et al.. (2008). Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. Journal of Hepatology. 48(6). 903–913. 56 indexed citations
6.
Nakamoto, Nobuhiro, David E. Kaplan, Yun Li, et al.. (2008). Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and Compartmentalization. Gastroenterology. 134(7). 1927–1937.e2. 236 indexed citations
7.
Kaplan, David E., Kazushi Sugimoto, Kimberly P. Newton, et al.. (2007). BASIC-LIVER, PANCREAS, AND BILIARY TRACT Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C. 1 indexed citations
8.
Kaplan, David E., Kazushi Sugimoto, Kimberly P. Newton, et al.. (2006). Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C. Gastroenterology. 132(2). 654–666. 116 indexed citations
9.
Kaplan, David E., Kazushi Sugimoto, Fusao Ikeda, et al.. (2005). T‐cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C†. Hepatology. 41(6). 1365–1375. 42 indexed citations
10.
Kaplan, David E., Keiko Sugimoto, Fusako Ikeda, et al.. (2003). 409 Differential mechanism of interferon-induced and spontaneous clearance of hepatitis C virus infection. Hepatology. 38. 357–357. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026